OrphanDrug
OrphanDrug
Pharma Knowledge Base

agenesis of the corpus callosum

MeSH: D061085ORPHA: 200

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with agenesis of the corpus callosum, sourced from HPO and Orphanet clinical annotations.

Agenesis of corpus callosumShort attention spanDelayed speech and language developmentHypotoniaSpecific learning disabilityDysphagiaModerate intellectual disabilityIncoordinationLanguage impairmentDyslexiaSevere intellectual disabilityAbnormally slow thought processDysorthography

Classification & Codes

MeSH Code

D061085

Orphanet Code

ORPHA:200
agenesis of the corpus callosum
MeSHD061085
OrphanetORPHA:200
Treatments0 drug(s)
Symptoms on record13 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO